PTCB Sterile Compounding/Aseptic Technique

parenteral solution

• complex admixtures composed of dextrose, fat, protein, electrolytes, vitamins, and trace elements. They are hypertonic solutions

• generally contained in ampules or vials

• typically bags o bottles containing larger volumes of intravenous solutions

• a product that is prepared in a sterile environment for administration by injection

large volume parenteral solutions

• complex admixtures composed of dextrose, fat, protein, electrolytes, vitamins, and trace elements. They are hypertonic solutions

• generally contained in ampules or vials

• typically bags or bottles containing larger volumes of intravenous solutions

• a product that is prepared in a sterile environment for administration by injection

small volume parenteral solutions

• complex admixtures composed of dextrose, fat, protein, electrolytes, vitamins, and trace elements. They are hypertonic solutions

• generally contained in ampules or vials

• typically bags or bottles containing larger volumes of intravenous solutions

• a product that is prepared in a sterile environment for administration by injection

total parenteral nutrition solution

• complex admixtures composed of dextrose, fat, protein, electrolytes, vitamins, and trace elements. They are hypertonic solutions

• generally contained in ampules or vials

• typically bags or bottles containing larger volumes of intravenous solutions

• a product that is prepared in a sterile environment for administration by injection

Which of the following is NOT a required property of solutions used for injection or infusion?

• sterile

• free of visible particulate material

• warmed to body temperature

• pyrogen free

Which of the following is NOT a required property of solutions used for injection or infusion?

• stable for their intended use

• have a pH around 7.4

• isotonic

• extremely viscous

A set of enforceable sterile compounding standards. It applies to compounding pharmacies and facilities involved in the preparation of compounded sterile preparations. Published by the united States Pharmacopeia.

• USP 707

• Drug quality and security act

• USP 795

• USP 797

legislation passed by the US congress that affects compounding practice

• USP 707

• Drug quality and security act

• USP 795

• USP 797

when a drug is added to a parenteral solution, the drug is referred to as the additive, and the final mixture is referred to as the _________________

• admixture

• IV fat emulsions

• peritoneal dialysis solutions

• heparin lock

required as a source of essential fatty acids. Also used as a concentrated source of calories. May be admixed into teh parenteral nutrition solution

• admixture

• IV fat emulsions

• peritoneal dialysis solutions

• heparin lock